First Trust Nasdaq Pharmaceuticals ETF (FTXH)
NASDAQ: FTXH · Real-Time Price · USD
40.68
+0.22 (0.56%)
Oct 7, 2026, 4:00 PM EDT - Market closed
FTXH Holdings Information
FTXH is an equity ETF with a total of 51 individual holdings. The top holdings are AbbVie stock at 7.63%, Eli Lilly and Company at 7.34%, Pfizer at 7.09%, Merck & Co. at 7.04%, and Johnson & Johnson at 7.03%.
Total Holdings
51
Top 10 Percentage
54.29%
Asset Class
Equity
ETF Category
Health
Assets
1.04B
PE Ratio
22.57
Breakdown by Country
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | ABBV | AbbVie Inc. | 7.63% |
| 2 | LLY | Eli Lilly and Company | 7.34% |
| 3 | PFE | Pfizer Inc. | 7.09% |
| 4 | MRK | Merck & Co., Inc. | 7.04% |
| 5 | JNJ | Johnson & Johnson | 7.03% |
| 6 | VTRS | Viatris Inc. | 3.90% |
| 7 | BIIB | Biogen Inc. | 3.77% |
| 8 | GILD | Gilead Sciences, Inc. | 3.61% |
| 9 | UTHR | United Therapeutics Corporation | 3.45% |
| 10 | AMGN | Amgen Inc. | 3.43% |
| 11 | ZTS | Zoetis Inc. | 3.39% |
| 12 | REGN | Regeneron Pharmaceuticals, Inc. | 3.39% |
| 13 | VRTX | Vertex Pharmaceuticals Incorporated | 3.38% |
| 14 | INCY | Incyte Corporation | 3.32% |
| 15 | BMY | Bristol-Myers Squibb Company | 3.27% |
| 16 | JAZZ | Jazz Pharmaceuticals plc | 2.70% |
| 17 | EXEL | Exelixis, Inc. | 2.38% |
| 18 | ILMN | Illumina, Inc. | 2.32% |
| 19 | HALO | Halozyme Therapeutics, Inc. | 1.61% |
| 20 | MEDP | Medpace Holdings, Inc. | 1.52% |
| 21 | NBIX | Neurocrine Biosciences, Inc. | 1.26% |
| 22 | BMRN | BioMarin Pharmaceutical Inc. | 1.21% |
| 23 | ELAN | Elanco Animal Health Incorporated | 1.18% |
| 24 | ALNY | Alnylam Pharmaceuticals, Inc. | 1.18% |
| 25 | CRL | Charles River Laboratories International, Inc. | 1.08% |
As of Oct 6, 2026